CDC20 has an oncogenic function in tumourigenesis [97], and its expression has been reported to be inhibited in vitro by curcumin and rottlerin, resulting in reduced survival of pancreatic cancer cells [98] and glioma cells [99]. This evidence concerns the gene CDC20 and central nervous system cancer.